Correlation Between Apogee Therapeutics, and 26444HAL5

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and 26444HAL5 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and 26444HAL5 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and DUK 3 15 DEC 51, you can compare the effects of market volatilities on Apogee Therapeutics, and 26444HAL5 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of 26444HAL5. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and 26444HAL5.

Diversification Opportunities for Apogee Therapeutics, and 26444HAL5

0.27

Correlation Coefficient

Apogee Therapeutics,  26444HAL5

Modest diversification

The 3 months correlation between Apogee and 26444HAL5 is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and DUK 3 15 DEC 51 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 26444HAL5 and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with 26444HAL5. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 26444HAL5 has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and 26444HAL5 go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and 26444HAL5

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the 26444HAL5. In addition to that, Apogee Therapeutics, is 1.81 times more volatile than DUK 3 15 DEC 51. It trades about -0.02 of its total potential returns per unit of risk. DUK 3 15 DEC 51 is currently generating about 0.04 per unit of volatility. If you would invest  6,704  in DUK 3 15 DEC 51 on October 10, 2024 and sell it today you would earn a total of  205.00  from holding DUK 3 15 DEC 51 or generate 3.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	67.74%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  DUK 3 15 DEC 51

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

26444HAL5

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in DUK 3 15 DEC 51 are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 26444HAL5 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Apogee Therapeutics, and 26444HAL5

The main advantage of trading using opposite Apogee Therapeutics, and 26444HAL5 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, 26444HAL5 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 26444HAL5 will offset losses from the drop in 26444HAL5's long position.

The idea behind Apogee Therapeutics, Common and DUK 3 15 DEC 51 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.